vitiligo. Vitiligo
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Clinical diagnosis of vitiligo recently or in case of previous diagnosis of non-drug use from one month ago Normal blood, liver, kidney, anti-nuclear antibody (ANA) tests and eye examination
Exclusion criteria
Exclusion criteria: Use of effective concomitant treatment in vitiligo Pregnancy Personal or family history of light-sensitive Suffering from light-sensitive diseases such as lupus and porphyria Use of light-sensitizing drugs such as retinoids and cotrimoxazole
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Size of skin lesions. Timepoint: At the beginning of the study, after 20 days, after a month, after two months. Method of measurement: Based on standard grading VASI and VIDA.;Color of skin lesions. Timepoint: At the beginning of the study, after 20 days, after a month, after two months. Method of measurement: Based on standard grading VASI and VIDA.;Follicular pigmentation. Timepoint: At the beginning of the study, after 20 days, after a month, after two months. Method of measurement: Based on standard grading VASI and VIDA. | — |
Countries
Iran (Islamic Republic of)
Contacts
Hamedan University of Medical Sciences